Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Bonora

Showing results (271-280 of 302) with videos related to

Pageof 31
Sort By:
British Journal of Clinical Pharmacology|September 17, 2022
Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIVMicol Ferrara, Jessica Cusato, Elena Salvador, et al.
Antioxidants (Basel, Switzerland)|January 25, 2025
How Antiretroviral Drug Concentrations Could Be Affected by Oxidative Stress, Physical Capacities and Genetics: A Focus on Dolutegravir Treated Male PLWHJessica Cusato, Anna Mulasso, Micol Ferrara, et al.
Plos One|September 28, 2019
A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)Cristina Mussini, Enrica Roncaglia, Vanni Borghi, et al.
Therapeutic Drug Monitoring|November 15, 2012
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatmentAntonio D'Avolio, Alessia Ciancio, Marco Siccardi, et al.
Expert Review of Anti-Infective Therapy|October 15, 2020
Enhancing care for people living with HIV: current and future monitoring approachesFranco Maggiolo, Alessandra Bandera, Stefano Bonora, et al.
Immunity, Inflammation and Disease|February 25, 2023
Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort studyFrancesca Pennati, Stefano Calza, Antonio Di Biagio, et al.
Antioxidants (Basel, Switzerland)|May 25, 2024
Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual TherapyJessica Cusato, Anna Mulasso, Micol Ferrara, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 17, 2016
Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter studySebastiano Gili, Massimo Mancone, Flavia Ballocca, et al.
AIDS Reviews|November 24, 2005
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus WorkshopGiampiero Carosi, Massimo Puoti, Giovanni Antonucci, et al.
BMJ Mental Health|August 11, 2023
Evaluation of telepsychiatry during the COVID-19 pandemic across service users, carers and clinicians: an international mixed-methods studyRebecca Sheriff, James S W Hong, Catherine Henshall, et al.
Pageof 31

Showing results (271-280 of 302) with videos related to

Sort By:
Pageof 31
British Journal of Clinical Pharmacology|September 17, 2022
Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIVMicol Ferrara, Jessica Cusato, Elena Salvador, et al.
Antioxidants (Basel, Switzerland)|January 25, 2025
How Antiretroviral Drug Concentrations Could Be Affected by Oxidative Stress, Physical Capacities and Genetics: A Focus on Dolutegravir Treated Male PLWHJessica Cusato, Anna Mulasso, Micol Ferrara, et al.
Plos One|September 28, 2019
A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)Cristina Mussini, Enrica Roncaglia, Vanni Borghi, et al.
Therapeutic Drug Monitoring|November 15, 2012
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatmentAntonio D'Avolio, Alessia Ciancio, Marco Siccardi, et al.
Expert Review of Anti-Infective Therapy|October 15, 2020
Enhancing care for people living with HIV: current and future monitoring approachesFranco Maggiolo, Alessandra Bandera, Stefano Bonora, et al.
Immunity, Inflammation and Disease|February 25, 2023
Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort studyFrancesca Pennati, Stefano Calza, Antonio Di Biagio, et al.
Antioxidants (Basel, Switzerland)|May 25, 2024
Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual TherapyJessica Cusato, Anna Mulasso, Micol Ferrara, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 17, 2016
Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter studySebastiano Gili, Massimo Mancone, Flavia Ballocca, et al.
AIDS Reviews|November 24, 2005
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus WorkshopGiampiero Carosi, Massimo Puoti, Giovanni Antonucci, et al.
BMJ Mental Health|August 11, 2023
Evaluation of telepsychiatry during the COVID-19 pandemic across service users, carers and clinicians: an international mixed-methods studyRebecca Sheriff, James S W Hong, Catherine Henshall, et al.
Pageof 31